1 Ruocco MG, Chaouat G, Florez L, Bensussan A,Klatzmann D. Regulatory T-cells in pregnancy: historical perspective, state of the art, and burning questions. Front Immunol. 2014; 5:389.
2 Wing JB, Tay C,Sakaguchi S. Control of Regulatory T Cells by Co-signal Molecules. Adv Exp Med Biol. 2019; 1189:179-210.
3 Somerset DA, Zheng Y, Kilby MD, Sansom DM,Drayson MT. Normal human pregnancy is associated with an elevation in the immune suppressive CD25+ CD4+ regulatory T-cell subset. Immunology. 2004; 112:38-43.
4 Wang WJ, Hao CF, Qu QL, Wang X, Qiu LH,Lin QD. The deregulation of regulatory T cells on interleukin-17-producing T helper cells in patients with unexplained early recurrent miscarriage. Hum Reprod. 2010; 25:2591-6.
5 Yang Y, Liu L, Liu B, Li Q, Wang Z, Fan S, Wang H,Wang L. Functional Defects of Regulatory T Cell Through Interleukin 10 Mediated Mechanism in the Induction of Gestational Diabetes Mellitus. DNA Cell Biol. 2018; 37:278-285.
6 Eller K, Kirsch A, Wolf AM, Sopper S, Tagwerker A, Stanzl U, Wolf D, Patsch W, Rosenkranz AR,Eller P. Potential role of regulatory T cells in reversing obesity-linked insulin resistance and diabetic nephropathy. Diabetes. 2011; 60:2954-62.
7 Feuerer M, Hill JA, Mathis D,Benoist C. Foxp3+ regulatory T cells: differentiation, specification, subphenotypes. Nat Immunol. 2009; 10:689-95.
8 Lobo TF, Borges CM, Mattar R, Gomes CP, de Angelo AGS, Pendeloski KPT,Daher S. Impaired Treg and NK cells profile in overweight women with gestational diabetes mellitus. 2018; 79.
9 Sifnaios E, Mastorakos G, Psarra K, Panagopoulos ND, Panoulis K, Vitoratos N, Rizos D,Creatsas G. Gestational Diabetes and T-cell (Th1/Th2/Th17/Treg) Immune Profile. In Vivo. 2019; 33:31-40.
10 Zhang S, Ke X, Zeng S, Wu M, Lou J, Wu L, Huang P, Huang L, Wang F,Pan S. Analysis of CD8+ Treg cells in patients with ovarian cancer: a possible mechanism for immune impairment. Cell Mol Immunol. 2015; 12:580-91.
11 Filaci G, Fenoglio D,Indiveri F. CD8(+) T regulatory/suppressor cells and their relationships with autoreactivity and autoimmunity. Autoimmunity. 2011; 44:51-7.
12 Bernuzzi F, Fenoglio D, Battaglia F, Fravega M, Gershwin ME, Indiveri F, Ansari AA, Podda M, Invernizzi P,Filaci G. Phenotypical and functional alterations of CD8 regulatory T cells in primary biliary cirrhosis. J Autoimmun. 2010; 35:176-80.
13 Smith TR,Kumar V. Revival of CD8+ Treg-mediated suppression. Trends Immunol. 2008; 29:337-42.
14 Zheng J, Liu Y, Qin G, Chan PL, Mao H, Lam KT, Lewis DB, Lau YL,Tu W. Efficient induction and expansion of human alloantigen-specific CD8 regulatory T cells from naive precursors by CD40-activated B cells. J Immunol. 2009; 183:3742-50.
15 Zhang B, Chikuma S, Hori S, Fagarasan S,Honjo T. Nonoverlapping roles of PD-1 and FoxP3 in maintaining immune tolerance in a novel autoimmune pancreatitis mouse model. Proc Natl Acad Sci U S A. 2016; 113:8490-5.
16 Kamada T, Togashi Y, Tay C, Ha D, Sasaki A, Nakamura Y, Sato E, Fukuoka S, Tada Y, Tanaka A, Morikawa H, Kawazoe A, Kinoshita T, Shitara K, Sakaguchi S,Nishikawa H. PD-1(+) regulatory T cells amplified by PD-1 blockade promote hyperprogression of cancer. Proc Natl Acad Sci U S A. 2019; 116:9999-10008.
17 Zhang Y, Liu Z, Tian M, Hu X, Wang L, Ji J,Liao A. The altered PD-1/PD-L1 pathway delivers the 'one-two punch' effects to promote the Treg/Th17 imbalance in pre-eclampsia. Cell Mol Immunol. 2018; 15:710-723.
18 Izawa A, Yamaura K, Albin MJ, Jurewicz M, Tanaka K, Clarkson MR, Ueno T, Habicht A, Freeman GJ, Yagita H, Abdi R, Pearson T, Greiner DL, Sayegh MH,Najafian N. A novel alloantigen-specific CD8+PD1+ regulatory T cell induced by ICOS-B7h blockade in vivo. J Immunol. 2007; 179:786-96.
19 Heikkinen J, Mottonen M, Alanen A,Lassila O. Phenotypic characterization of regulatory T cells in the human decidua. Clin Exp Immunol. 2004; 136:373-8.
20 Placke T, Kopp HG,Salih HR. Glucocorticoid-induced TNFR-related (GITR) protein and its ligand in antitumor immunity: functional role and therapeutic modulation. Clin Dev Immunol. 2010; 2010:239083.
21 Zou Q, Wu B, Xue J, Fan X, Feng C, Geng S, Wang M,Wang B. CD8+ Treg cells suppress CD8+ T cell-responses by IL-10-dependent mechanism during H5N1 influenza virus infection. Eur J Immunol. 2014; 44:103-14.
22 Mahne AE, Mauze S, Joyce-Shaikh B, Xia J, Bowman EP, Beebe AM, Cua DJ,Jain R. Dual Roles for Regulatory T-cell Depletion and Costimulatory Signaling in Agonistic GITR Targeting for Tumor Immunotherapy. Cancer Res. 2017; 77:1108-1118.
23 Knee DA, Hewes B,Brogdon JL. Rationale for anti-GITR cancer immunotherapy. Eur J Cancer. 2016; 67:1-10.
24 Bianchini R, Bistoni O, Alunno A, Petrillo MG, Ronchetti S, Sportoletti P, Bocci EB, Nocentini G, Gerli R,Riccardi C. CD4(+) CD25(low) GITR(+) cells: a novel human CD4(+) T-cell population with regulatory activity. Eur J Immunol. 2011; 41:2269-78.
25 Ronchetti S, Nocentini G, Bianchini R, Krausz LT, Migliorati G,Riccardi C. Glucocorticoid-induced TNFR-related protein lowers the threshold of CD28 costimulation in CD8+ T cells. J Immunol. 2007; 179:5916-26.
26 Ishitani A, Sageshima N, Lee N, Dorofeeva N, Hatake K, Marquardt H,Geraghty DE. Protein expression and peptide binding suggest unique and interacting functional roles for HLA-E, F, and G in maternal-placental immune recognition. J Immunol. 2003; 171:1376-84.
27 Feger U, Tolosa E, Huang YH, Waschbisch A, Biedermann T, Melms A,Wiendl H. HLA-G expression defines a novel regulatory T-cell subset present in human peripheral blood and sites of inflammation. Blood. 2007; 110:568-77.
28 Huang YH, Zozulya AL, Weidenfeller C, Schwab N,Wiendl H. T cell suppression by naturally occurring HLA-G-expressing regulatory CD4+ T cells is IL-10-dependent and reversible. J Leukoc Biol. 2009; 86:273-81.
29 Lozano JM, Gonzalez R, Luque J, Frias M, Rivero A,Pena J. CD8(+)HLA-G(+) regulatory T cells are expanded in HIV-1-infected patients. Viral Immunol. 2009; 22:463-5.
30 Li C, Toth I, Schulze Zur Wiesch J, Pereyra F, Rychert J, Rosenberg ES, van Lunzen J, Lichterfeld M,Yu XG. Functional characterization of HLA-G(+) regulatory T cells in HIV-1 infection. PLoS Pathog. 2013; 9:e1003140.
31 Jarvis LB, Goodall JC,Gaston JS. Human leukocyte antigen class I-restricted immunosuppression by human CD8+ regulatory T cells requires CTLA-4-mediated interaction with dendritic cells. Hum Immunol. 2008; 69:687-95.
32 Hou TZ, Qureshi OS,Sansom DM. Measuring CTLA-4-Dependent Suppressive Function in Regulatory T Cells. Methods Mol Biol. 2019; 1899:87-101.
33 Olson BM, Jankowska-Gan E, Becker JT, Vignali DA, Burlingham WJ,McNeel DG. Human prostate tumor antigen-specific CD8+ regulatory T cells are inhibited by CTLA-4 or IL-35 blockade. J Immunol. 2012; 189:5590-601.
34 Bender Atik R, Christiansen OB, Elson J, Kolte AM, Lewis S, Middeldorp S, Nelen W, Peramo B, Quenby S,Vermeulen N. ESHRE guideline: recurrent pregnancy loss. 2018; 2018:hoy004.
35 Metzger BE, Gabbe SG, Persson B, Buchanan TA, Catalano PA, Damm P, Dyer AR, Leiva A, Hod M, Kitzmiler JL, Lowe LP, McIntyre HD, Oats JJ, Omori Y,Schmidt MI. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care. 2010; 33:676-82.
36 Shilov ES. [Body's Own Epitopes among Foreign Ones: T Cells and Autoantigens]. Mol Biol (Mosk). 2019; 53:849-859.
37 Yoo JH, Kwak-Kim J, Han AR, Ahn H, Cha SH, Koong MK, Kang IS,Yang KM. Peripheral blood NK cell cytotoxicities are negatively correlated with CD8(+) T cells in fertile women but not in women with a history of recurrent pregnancy loss. Am J Reprod Immunol. 2012; 68:38-46.
38 Kwak JY, Beaman KD, Gilman-Sachs A, Ruiz JE, Schewitz D,Beer AE. Up-regulated expression of CD56+, CD56+/CD16+, and CD19+ cells in peripheral blood lymphocytes in pregnant women with recurrent pregnancy losses. Am J Reprod Immunol. 1995; 34:93-9.
39 Yahata T, Kurabayashi T, Honda A, Takakuwa K, Tanaka K,Abo T. Decrease in the proportion of granulated CD56+ T-cells in patients with a history of recurrent abortion. J Reprod Immunol. 1998; 38:63-73.
40 Wang WJ, Liu FJ, Zhang X, Liu XM, Qu QL, Li FH, Zhuang LL, Li XX,Hao CF. Periodic elevation of regulatory T cells on the day of embryo transfer is associated with better in vitro fertilization outcome. J Reprod Immunol. 2017; 119:49-53.
41 Wang WJ, Liu FJ, Xin L, Hao CF, Bao HC, Qu QL,Liu XM. Adoptive transfer of pregnancy-induced CD4+CD25+ regulatory T cells reverses the increase in abortion rate caused by interleukin 17 in the CBA/JxBALB/c mouse model. Hum Reprod. 2014; 29:946-52.
42 Tilburgs T, Roelen DL, van der Mast BJ, van Schip JJ, Kleijburg C, de Groot-Swings GM, Kanhai HH, Claas FH,Scherjon SA. Differential distribution of CD4(+)CD25(bright) and CD8(+)CD28(-) T-cells in decidua and maternal blood during human pregnancy. Placenta. 2006; 27 Suppl A:S47-53.
43 Tilburgs T,Strominger JL. CD8+ effector T cells at the fetal-maternal interface, balancing fetal tolerance and antiviral immunity. Am J Reprod Immunol. 2013; 69:395-407.
44 Vianna P, Mondadori AG, Bauer ME, Dornfeld D,Chies JA. HLA-G and CD8+ regulatory T cells in the inflammatory environment of pre-eclampsia. Reproduction. 2016; 152:741-751.
45 Dai H, Wan N, Zhang S, Moore Y, Wan F,Dai Z. Cutting edge: programmed death-1 defines CD8+CD122+ T cells as regulatory versus memory T cells. J Immunol. 2010; 185:803-7.
46 Chikuma S, Terawaki S, Hayashi T, Nabeshima R, Yoshida T, Shibayama S, Okazaki T,Honjo T. PD-1-mediated suppression of IL-2 production induces CD8+ T cell anergy in vivo. J Immunol. 2009; 182:6682-9.
47 van der Merwe M, Abdelsamed HA, Seth A, Ong T, Vogel P,Pillai AB. Recipient myeloid-derived immunomodulatory cells induce PD-1 ligand-dependent donor CD4+Foxp3+ regulatory T cell proliferation and donor-recipient immune tolerance after murine nonmyeloablative bone marrow transplantation. J Immunol. 2013; 191:5764-76.
48 Francisco LM, Salinas VH, Brown KE, Vanguri VK, Freeman GJ, Kuchroo VK,Sharpe AH. PD-L1 regulates the development, maintenance, and function of induced regulatory T cells. J Exp Med. 2009; 206:3015-29.
49 Machicote A, Belen S, Baz P, Billordo LA,Fainboim L. Human CD8(+)HLA-DR(+) Regulatory T Cells, Similarly to Classical CD4(+)Foxp3(+) Cells, Suppress Immune Responses via PD-1/PD-L1 Axis. Front Immunol. 2018; 9:2788.
50 Wang SC, Li YH, Piao HL, Hong XW, Zhang D, Xu YY, Tao Y, Wang Y, Yuan MM, Li DJ,Du MR. PD-1 and Tim-3 pathways are associated with regulatory CD8+ T-cell function in decidua and maintenance of normal pregnancy. Cell Death Dis. 2015; 6:e1738.
51 Leung CS, Yang KY, Li X, Chan VW, Ku M, Waldmann H, Hori S, Tsang JCH, Lo YMD,Lui KO. Single-cell transcriptomics reveal that PD-1 mediates immune tolerance by regulating proliferation of regulatory T cells. 2018; 10:71.
52 Ye X, Ju S, Duan H, Yao Y, Wu J, Zhong S, Chen L, Cao S, Xu Y, Zheng X, Wang H, Ge Y,Ju S. Immune checkpoint molecule PD-1 acts as a novel biomarker for the pathological process of gestational diabetes mellitus. Biomark Med. 2017; 11:741-749.
53 Li G, Lu C, Gao J, Wang X, Wu H, Lee C, Xing B,Zhang Q. Association between PD-1/PD-L1 and T regulate cells in early recurrent miscarriage. Int J Clin Exp Pathol. 2015; 8:6512-8.
54 Liao G, Nayak S, Regueiro JR, Berger SB, Detre C, Romero X, de Waal Malefyt R, Chatila TA, Herzog RW,Terhorst C. GITR engagement preferentially enhances proliferation of functionally competent CD4+CD25+FoxP3+ regulatory T cells. Int Immunol. 2010; 22:259-70.
55 Ghaebi M, Abdolmohammadi-Vahid S, Ahmadi M, Eghbal-Fard S, Dolati S, Nouri M, Talebi M, Hamdi K, Marofi F, Aghebati-Maleki L, Jadidi-Niaragh F, Dopour M,Yousefi M. T cell Subsets in Peripheral Blood of Women with Recurrent Implantation Failure. J Reprod Immunol. 2019; 131:21-29.
56 Saifi B, Aflatoonian R, Tajik N, Erfanian Ahmadpour M, Vakili R, Amjadi F, Valizade N, Ahmadi S, Rezaee SA,Mehdizadeh M. T regulatory markers expression in unexplained recurrent spontaneous abortion. J Matern Fetal Neonatal Med. 2016; 29:1175-80.
57 Papamitsou T, Toskas A, Papadopoulou K, Sioga A, Lakis S, Chatzistamatiou M, Economou Z,Adriopoulou L. Immunohistochemical study of immunological markers: HLAG, CD16, CD25, CD56 and CD68 in placenta tissues in recurrent pregnancy loss. Histol Histopathol. 2014; 29:1047-55.
58 Pankratz S, Bittner S, Herrmann AM, Schuhmann MK, Ruck T, Meuth SG,Wiendl H. Human CD4+ HLA-G+ regulatory T cells are potent suppressors of graft-versus-host disease in vivo. Faseb j. 2014; 28:3435-45.
59 Zare M, Namavar Jahromi B,Gharesi-Fard B. Analysis of the frequencies and functions of CD4(+)CD25(+)CD127(low/neg), CD4(+)HLA-G(+), and CD8(+)HLA-G(+) regulatory T cells in pre-eclampsia. J Reprod Immunol. 2019; 133:43-51.
60 Mosaferi E,Alizadeh Gharamaleki N. The Study of HLA-G Gene and Protein Expression in Patients with Recurrent Miscarriage. 2019; 9:70-75.
61 Prins JR, van der Hoorn MLP, Keijser R, Ris-Stalpers C, van Beelen E, Afink GB, Claas FHJ, van der Post JAM,Scherjon SA. Higher decidual EBI3 and HLA-G mRNA expression in preeclampsia: Cause or consequence of preeclampsia. Hum Immunol. 2016; 77:68-70.
62 Rathod SB, Das R, Thanapati S, Arankalle VA,Tripathy AS. Suppressive activity and altered conventional phenotype markers/mediators of regulatory T cells in patients with self-limiting hepatitis E. J Viral Hepat. 2014; 21:141-51.
63 Miwa N, Hayakawa S, Miyazaki S, Myojo S, Sasaki Y, Sakai M, Takikawa O,Saito S. IDO expression on decidual and peripheral blood dendritic cells and monocytes/macrophages after treatment with CTLA-4 or interferon-gamma increase in normal pregnancy but decrease in spontaneous abortion. Mol Hum Reprod. 2005; 11:865-70.
64 Jin LP, Chen QY, Zhang T, Guo PF,Li DJ. The CD4+CD25 bright regulatory T cells and CTLA-4 expression in peripheral and decidual lymphocytes are down-regulated in human miscarriage. Clin Immunol. 2009; 133:402-10.
65 Huang X, Cai Y, Ding M, Zheng B, Sun H,Zhou J. Human chorionic gonadotropin promotes recruitment of regulatory T cells in endometrium by inducing chemokine CCL2. J Reprod Immunol. 2019; 137:102856.
66 Tilburgs T, Roelen DL, van der Mast BJ, de Groot-Swings GM, Kleijburg C, Scherjon SA,Claas FH. Evidence for a selective migration of fetus-specific CD4+CD25bright regulatory T cells from the peripheral blood to the decidua in human pregnancy. J Immunol. 2008; 180:5737-45.